Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.23.3
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current:    
Cash and cash equivalents $ 6,472 $ 12,449
Restricted cash 66 439
Accounts receivable, net 1,746 2,252
Prepaids, deposits and other receivables 1,941 2,708
Inventories, net 7,709 8,399
Total current assets 17,934 26,247
Investment – Cansativa 1,896 5,679
Property, plant and equipment, net of accumulated depreciation of $8,389 and $7,120 for September 30, 2023 and December 31, 2022, respectively 12,752 13,963
Assets held for sale - Land 1,500 1,500
Intangible assets, net 2,821 3,354
Operating lease right-of-use assets, net 820 1,303
Other non-current assets 54 52
Total Assets 37,777 52,098
Current:    
Accounts payable 2,088 2,299
Accrued expenses and other current liabilities 3,225 4,238
Loans and borrowings, current portion 477 465
Warrant liability 108 113
Operating lease liabilities, current portion 512 1,239
Deferred revenue 437 1,072
Total current liabilities 6,847 9,426
Loans and borrowing — long-term 859 1,065
Operating lease liabilities — long-term 366 1,087
Other long-term liabilities 16 112
Total Liabilities 8,088 11,690
Contingencies and commitments
Shareholders’ equity    
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of September 30, 2023 and December 31, 2022 0 0
Common shares, without par value, unlimited shares authorized: 1,726,145 and 1,454,559 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 0 0
Additional paid-in capital 223,407 221,313
Accumulated deficit (193,718) (180,905)
Total shareholders' equity 29,689 40,408
Total liabilities and shareholders' equity $ 37,777 $ 52,098